(Q38829578)

6 September 2017

title

Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer (English)

1 reference

6 September 2017

Hong-Yi Kuo

1

1 reference

6 September 2017

Hsiao-Ting Hsu

2

1 reference

6 September 2017

Yi-Chen Chen

3

1 reference

6 September 2017

Yu-Wei Chang

4

1 reference

6 September 2017

Fu-Tong Liu

5

1 reference

6 September 2017

Cheng-Wen Wu

6

1 reference

6 September 2017

publication date

6 October 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

26

1 reference

6 September 2017

issue

2

1 reference

6 September 2017

page(s)

155-165

1 reference

EGFR kinase promotes acquisition of stem cell-like properties: a potential therapeutic target in head and neck squamous cell carcinoma stem cells

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Understanding and targeting cancer stem cells: therapeutic implications and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

The emerging role of SOX2 in cell proliferation and survival and its crosstalk with oncogenic signaling in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3: a novel mediator of heart failure development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

A methylation-phosphorylation switch determines Sox2 stability and function in ESC maintenance or differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Histone acetylation is associated with differential gene expression in the rapid and robust memory CD8(+) T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

The EGFR family: not so prototypical receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after neural injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3 regulates intracellular trafficking of EGFR through Alix and promotes keratinocyte migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

The multiple roles for Sox2 in stem cell maintenance and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectins as modulators of tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Evidence that SOX2 overexpression is oncogenic in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Regulation of alternative macrophage activation by galectin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Proteomic comparison of mcf-7 tumoursphere and monolayer cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Induction of cancer stem cell properties in colon cancer cells by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Transcriptional regulation of nanog by OCT4 and SOX2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Mutational tuning of galectin-3 specificity and biological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

The Carbohydrate-Binding Site in Galectin-3 Is Preorganized To Recognize a Sugarlike Framework of Oxygens: Ultra-High-Resolution Structures and Water Dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Global cancer statistics, 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Therapy of experimental NASH and fibrosis with galectin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Cancer stem cells and drug resistance: the potential of nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppression [correction of suppresion] of activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FGLYCOB%2FCWV088

21 January 2018

Identifiers

DOI

10.1093/GLYCOB/CWV088

1 reference

6 September 2017

1 reference